IU Health Goshen Hospital

Goshen, Indiana 46527

0 studies enrolling now · 5 studies all time

What they study most

Bladder Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Malignant Neoplasm of Breast, Metastatic Castrate-Resistant Prostate Cancer, PSA, Prostate Cancer, Urothelial Carcinoma

Studies at this site

• Randomized Controlled Trial of Genomically Directed Therapy in Patients With Triple Negative Breast Cancer — Completed
• Consolidation Pembrolizumab Following Chemoradiation in Patients With Inoperable/Unresectable Stage III NSCLC — Completed
• First-Line Gemcitabine, Cisplatin + Ipilimumab for Metastatic Urothelial Carcinoma — Completed
• OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone — Stopped early
• Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer — Completed